Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
You are welcomed to join a young, dynamic research group working translationally to understand how endothelial cells impact tissue functions beyond their delivery of oxygen in the context of metabolic disease. As a part of a well-established larger network of researchers in metabolism and...
-
single cell biology technologies as well as antibody engineering, high dimensional flow cytometry and functional assays to understand molecular mechanisms of various autoimmune diseases. The candidate will
-
for doctoral education . Skills and personal qualities We are seeking a highly motivated and scientifically driven individual to join our research team as a PhD candidate in cell biology. The ideal candidate
-
combination of advanced image processing, dedicated bioinformatic analysis, and experimental vascular biology. Based in a dynamic translational research environment of vascular surgery, biology, and imaging
-
biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of infection. For more information, please see: Data-Driven Life Science (DDLS) - SciLifeLab The future
-
of four years of full-time doctoral education is required. The research group The Eroglu Lab is part of the Cell and Molecular Biology Department and is located in Biomedicum. The research group combines
-
diversification in response to acute infection. The project involves work with murine and human primary T cells, infections, advanced flow cytometry, cell sorting, molecular biology and analysis of single-cell RNA
-
of four years of full-time doctoral education is required. The Department of Microbiology, Tumor and Cell Biology (MTC) at Karolinska Institutet conducts research and teaching within immunology, infection
-
program has four strategic areas: cell and molecular biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of infection. For more information, please see The
-
increasing the understanding of cancer biology at the proteome level. This enables the development of novel therapeutic strategies as well as the identification of biomarkers with predictive, prognostic and